January 30, 2026 a 07:43 am
CVS: Fundamental Ratio Analysis - CVS Health Corporation
CVS Health Corporation, a key player in the healthcare sector, exhibits stable fundamentals with a potential for moderate growth. The company's diversified business model ensures a robust presence in both pharmacy services and health care benefits, serving a vast demographic.
Fundamental Rating
Overall, CVS Health Corporation holds a 'B' rating, reflecting moderate strength in its financial management.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return On Equity | 2 | |
| Return On Assets | 3 | |
| Debt To Equity | 1 | |
| Price To Earnings | 1 | |
| Price To Book | 4 |
Historical Rating
The historical performance shows consistent scoring with signs of stability in key areas.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-01-29 | 3 | 5 | 2 | 3 | 1 | 1 | 4 |
| Previous Record | 0 | 5 | 2 | 3 | 1 | 1 | 4 |
Analyst Price Targets
The company's stock has a favorable outlook with the current analyst consensus being to 'Buy'.
| High | Low | Median | Consensus |
|---|---|---|---|
| $103 | $90 | $93 | $94.92 |
Analyst Sentiment
Analysts largely favor the stock with a strong buy recommendation being predominant.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 32 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
CVS Health Corporation stands as a favorable investment within the healthcare sector, fortified by its diversified service offerings and stable fundamentals. Despite a few lower scores in specific areas, the company maintains a strong industry position thanks to its expansive network and service quality. Given the current analyst recommendations and historical consistency, the stock promises moderate growth, although investors should remain vigilant about market conditions.